Challenges and missed opportunities in lithium monitoring for bipolar disorder: A reflection on Bosi et al.'s finding

Bipolar Disord. 2024 Jun;26(4):388-389. doi: 10.1111/bdi.13417. Epub 2024 Mar 18.

Authors

Thalles Rodrigues Alves Leite¹, Sergio Andre de Souza Junior², Ana Leticia Souza da Silva¹, Sarah Pereira Gomes¹, Fabio Gomes de Matos E Souza^{1

2

3}, Luisa Weber Bisol^{1

2

3}

Affiliations

¹ School of Medicine, Federal University of Ceara, Fortaleza, Brazil.
² Psychiatry Service, University Hospital Walter Cantidio, Federal University of Ceara, Fortaleza, Brazil.
³ Clinical Medicine Department, Federal University of Ceara, Fortaleza, Brazil.

PMID: 38499401
DOI: 10.1111/bdi.13417

No abstract available

Publication types

Letter

MeSH terms

Antimanic Agents* / therapeutic use
Bipolar Disorder* / drug therapy
Drug Monitoring / methods
Humans
Lithium Compounds / therapeutic use

Substances

Antimanic Agents
Lithium Compounds